Results 151 to 160 of about 3,493 (205)

Intraseasonal waning of influenza vaccine effectiveness and implications for the optimal timing of seasonal vaccination programs: A scoping review. [PDF]

Can Commun Dis Rep
Doyon-Plourde P, Tadount F, Gil A, Lazarescu C, Ursu MM, Sicard N, Siu W, Sinilaité A.   +7 more
europepmc   +1 more source

2026 Queensland LAIV Immunisation Program: Consumer preferences for messaging and resources

Australian and New Zealand Journal of Public Health
Rebecca Doyle, Tom Clayton, Scott Brown, Sophie Wen   +3 more
openaire   +1 more source

Vaccinating and non-vaccinating parents' attitudes toward influenza vaccination in children under 5 years old in Spain. [PDF]

Front Public Health
Zornoza-Moreno M, Sánchez-Manresa S, Gómez-Moreno MC, Ros Abellán MP, Pérez-Martín JJ.   +4 more
europepmc   +1 more source

Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - California, October 2025-January 2026. [PDF]

MMWR Morb Mortal Wkly Rep
Zhu S, Quint J, León TM, Li NJ, Muldrew S, Porse C, Flannery B, Ellington S, Murray EL, Sachdev D, McCullough K, Schechter R.   +11 more
europepmc   +1 more source

Effect of Seasonal Influenza Vaccines on Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Ferrets. [PDF]

Emerg Infect Dis
Sun X, Subbiah J, Belser JA, Brock N, Gansebom S, Li ZN, Jung YJ, Liu F, Tumpey TM, Maines TR, Levine MZ, York IA.   +11 more
europepmc   +1 more source

Nasal immunity in respiratory viral infection, transmission, and protection. [PDF]

Immunity
Kazer SW, Walsh JML, Juttukonda LJ, Ordovas-Montanes J.   +3 more
europepmc   +1 more source

Screening for next generation vaccines in human immune organoids. [PDF]

Immunohorizons
Chen GB, Smith A, Lee J, Kang P, Siva O, Davis MM.   +5 more
europepmc   +1 more source

SEA CDM: Study-Experiment-Assay Common Data Model and Databases for Cross-Domain Data Integration and Analysis. [PDF]

Sci Data
Huffman A, Yeh FY, Hur J, Zheng J, Masci AM, Wu G, Tao C, Athey B, He Y.   +8 more
europepmc   +1 more source

Differences in Glycoproteins and the Potential for Early Protection Using LAIV Based on Drift Variants of the A/H1N1pdm09 Influenza Virus. [PDF]

Vaccines (Basel)
Desheva Y, Mayorova I, Rekstin A, Sokolovsky D, Kudar P, Kopylova N, Guzenkov D, Petrachkova D, Mamontov A, Trullioff A, Kiseleva I.   +10 more
europepmc   +1 more source